<DOC>
	<DOCNO>NCT01451320</DOCNO>
	<brief_summary>Despite high mortality morbidity , best treatment strategy prosthetic valve thrombosis ( PVT ) controversial . In study investigator want identify effective safe regimen among different thrombolytic strategies.Transesophageal echocardiography ( TEE ) guide thrombolytic treatment administer 182 consecutive patient PVT 220 different episode ( 156 woman , mean age 43.2±13.06 year ) 1993 2009 . These regimen include rapid streptokinase ( Group I , 16 episode ) , slow streptokinase ( Group II , 41 episode ) , high dose ( 100 mg ) tissue plasminogen activator ( t-PA ) ( Group III , 12 episode ) , half-dose ( 50 mg ) slow infusion ( 6-hours ) t-PA without bolus ( Group IV , 27 episode ) , low dose ( 25 mg ) slow infusion ( 6-hours ) t-PA without bolus ( Group V , 124 episode ) . The study endpoints thrombolytic success in-hospital mortality non-fatal complication rate .</brief_summary>
	<brief_title>Comparison Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens prosthetIc vAlve Thrombosis</brief_title>
	<detailed_description>One hundred eighty two consecutive in-hospital patient 220 episode PVT 1993 2009 include study . The patient enrol informed consent contraindication , thrombolysis . The study approve local Ethics Board . The patient demographic , past medical history , date operation , type make prosthetic valve , rhythm disorder , aspirin use , NYHA functional capacity , lead symptom international normalization ratio ( INR ) value time admission prospectively enter database.The diagnosis PVT verify time transesophageal echocardiography ( TEE ) patient admit thromboembolism persistently low INR precede consecutive 3 month transthoracic echocardiography ( TTE ) document prosthetic valve dysfunction thrombus . All patient underwent TTE TEE examination thrombolysis session . The cross sectional area long diameter thrombus measure TEE recording</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<mesh_term>Streptokinase</mesh_term>
	<criteria>Patients prosthetic valve thrombosis Large leave atrial thrombus Recent ( &lt; 3 week ) ischemic stroke Hemorrhagic stroke Early ( &lt; 4 day ) postoperative period Traumatic accident &lt; 4 week Bleeding diathesis † İntracranial mass Active internal bleed Aortic dissection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Prosthetic valve</keyword>
	<keyword>thrombosis</keyword>
	<keyword>TROIA</keyword>
	<keyword>tPA</keyword>
	<keyword>TEE</keyword>
</DOC>